You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 4, 2024

CLINICAL TRIALS PROFILE FOR RAPASTINEL

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Rapastinel

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT02192099 ↗	Open Label Extension for GLYX13-C-202, NCT01684163	Terminated	Naurex, Inc	Phase 2	Examine the safety of long term repeat exposure to GLYX-13 in subjects who participated in GLYX13-C-202.
NCT02192099 ↗	Open Label Extension for GLYX13-C-202, NCT01684163	Terminated	Naurex, Inc, an affiliate of Allergan plc	Phase 2	Examine the safety of long term repeat exposure to GLYX-13 in subjects who participated in GLYX13-C-202.
NCT02267629 ↗	Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder	Completed	New York State Psychiatric Institute	Phase 2	This research study tests whether GLYX-13 - an experimental drug that acts on a brain receptor called NMDA - can decrease symptoms of OCD within hours. This is not a treatment study. Results from this study will allow doctors and researchers to better understand if you and others with OCD may respond to a class of medications that target the NMDA brain receptor.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Rapastinel

Condition Name

Chart
Table

Condition Name for
Intervention	Trials
Depressive Disorder, Major	11
Driving Performance	1
Human Abuse Potential	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for
Intervention	Trials
Depression	12
Depressive Disorder, Major	12
Depressive Disorder	12
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Rapastinel

Trials by Country

Map
Table

Trials by Country for
Location	Trials
United States	220
Canada	4
Poland	2
Ukraine	2
Japan	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for
Location	Trials
California	11
New York	11
Illinois	9
Texas	9
Georgia	9
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Rapastinel

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 3	10
Phase 2	3
Phase 1	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for
Clinical Trial Phase	Trials
Completed	8
Terminated	6
Withdrawn	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Rapastinel

Sponsor Name

Chart
Table

Sponsor Name for
Sponsor	Trials
Naurex, Inc, an affiliate of Allergan plc	14
Allergan	6
Naurex, Inc	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for
Sponsor	Trials
Industry	21
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.